Purchase Order 75N91023P00540

Award Date 6/27/23
Potential Completion Date 6/26/25
Potential Value $250K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute (NCI) has awarded a $248,767 firm fixed-price purchase order contract to Proton Doctors Professional Corporation for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. This contract is not set-aside. The goal is to obtain de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with...
The National Cancer Institute (NCI) awarded a $250,000 firm fixed-price purchase order to Baylor College of Medicine to establish the U.S. Pediatric Proton and Photon Therapy Cohort, a retrospective study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated at their institution with proton or photon therapy....
The National Cancer Institute (NCI) awarded a $293,970 firm fixed-price purchase order to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to retrieve existing clinical and treatment data for at least 500 pediatric cancer patients treated with photon therapy since 2007. This data will be used to evaluate photon therapy as a cancer treatment for pediatric patients as part of the U.S. Pediatric Photon Therapy Comparison Cohort Study. The...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute to The Washington University for $249,997 to provide medical record abstraction services in support of a study comparing pediatric proton and photon radiation therapy. The 14-month contract does not have a set-aside designation. The services will involve retrieving de-identified clinical and treatment data from medical records of pediatric cancer patients treated with proton or photon radiotherapy. This contract...
This federal contract award was made by the National Cancer Institute (NCI) to the University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System. The contract, valued at $247,116.20, is for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. MD Anderson will retrieve de-identified clinical and treatment data from existing...
This is a firm-fixed-price contract awarded by the National Cancer Institute (NCI) to Princeton Procure Management LLC (Procure Proton Center) for $150,150 to provide medical record abstraction services for a study comparing pediatric proton and photon radiotherapy. The 14-month contract, which starts on or about November 1, 2024, is part of NCI's Pediatric Proton and Photon Therapy Comparison Cohort program. The contractor will retrieve de-identified clinical and treatment data from medical...
This firm fixed price purchase order awarded by the National Institutes of Health's National Cancer Institute to Mayo Clinic seeks to obtain clinical data on pediatric cancer patients treated with proton therapy or photon therapy. The goal is to retrieve existing diagnosis and treatment data from medical records of eligible patients treated since January 2007 at contractor institutions and enter de-identified data into a secure database to serve as a comparison cohort for a US Pediatric Proton...
The National Institutes of Health's National Cancer Institute awarded a $249,323 firm fixed price purchase order to The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital. This contract is to serve as the Pediatric Proton and Photon Therapy Comparison Cohort Coordinating Center. Per the statement of work, the center will coordinate data collection and analysis from multiple pediatric cancer treatment sites comparing outcomes of patients...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order contract to The Ohio State University to obtain data on a group of proton-treated pediatric cancer patients and a comparison group of photon-treated pediatric cancer patients. The $243,347.00 contract has a completion date of September 14, 2023. The Ohio State University, a public research university, will retrieve existing medical record data on...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to retrieve existing clinical and treatment data for pediatric cancer patients treated with photon therapy at the university's institution. The $118,611.00 contract is part of the US Pediatric Photon Therapy Comparison Cohort Study, a program focused on...

The National Cancer Institute (NCI) has awarded a $249,814 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, for the US Pediatric Proton and Photon Therapy Cohort study. This retrospective cohort study aims to compare the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data from existing medical records to evaluate second cancer risks and other adverse effects between the two radiation therapy modalities. This contract has no set-aside designation. The study will build upon the foundation of the existing US Pediatric Proton Consortium Registry, which has enrolled over 3,000 pediatric proton therapy patients across 20 US centers since 2012. The goal is to quantify long-term health outcomes and risks for children undergoing these radiation therapies for cancer treatment.

Generated 6/12/24, 10:18 AM